BIT's 17th Annual Congress of International Drug Discovery Science & Technology-China 2019

● Designing 80+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops and Training Courses
● Inviting Worldwide Distinguished Experts, Investors, and Decision Makers in the areas of Drug Discovery for the Grand Thought Collision from 50+ Countries
● Shooting for 400+ Oral Presentations and Hot Paper Briefing in whole Spectrum of Drug Discovery Fields
● Gathering 50+ Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Bringing in 20+ Professional Media Supporters
● Scheduling 5+ Sessions of Business & Career Development, and Talent Search
● Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products

Keynote Speakers

Dr. Maode Lai
Academician of Nationale Akademie der Wissenschafte, President, China Pharmaceutical University, China


Dr. Christopher Abell
Fellow of the Royal Society, Pro-Vice-Chancellor for Research, The University of Cambridge, UK

Dr. Kaixian Chen
Academician, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, China

Dr. Ge Li
Chairman, WuXi AppTec Group, China

Dr. Henrietta Ukwu
Senior Vice President, Head of Global Regulatory Affairs, Otsuka, USA

Our Renowned Speakers
Dr. Richard Soll
Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA
Dr. Sudhakar Garad
Global Head, Chemical and Pharmaceutical Profiling, Novartis, USA
Dr. Stephan Zahn
Director, Boehringer Ingelheim RCV GmbH & Co KG, Austria
Dr. Zhenhong Li
Senior Director, REGENXBIO Inc., USA
Dr. Yoshinori Ikeura
CEO, Axcelead Drug Discovery Partners, Inc., R&D Committee of Japan Pharmaceuticals Manufacturers Association, Japan
Dr. David C. Bunton
Dr. Qidong You
Professor and Dean of School of Pharmacy, China Pharmaceutical University, China
Dr. Luzheng Xue
Professor, University of Oxford, UK
Dr. Bruce Given
COO, Arrowhead Research Corporation, USA
说明: scientificprogram3_clip_image006.jpg Dr. Dieter Lubda
Director, Merck KGaA, Germany
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Qi Yin
Clinical Sciences Therapeutic Area Head, Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, USA
Dr. Jeffery Liu
Director, GSK, USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Steffen Denzinger
Director, Strategy and Business Development Process Solutions, Merck Millipore, Germany
Dr. Tina Tao
Head of APAC E2E Biodevelopment Center, Merck Group, China
Dr. Kiyoshi Nokihara
CEO&CSO, HiPepLaboratories, Japan
Dr. Cheng Zhang
Chief Scientific Officer, Gmax BioPharm, China
Dr. Hong Ling
VP of Innovation, Head of Pipeline and Scientific Evaluation, Qilu Pharmaceuticals, China
说明: scientificprogram3_clip_image008.jpg Dr. Yan Wu
Vice President, Head of Clinical Operation and Head of Immunology Development, Hutchison Medi Pharma, China
Dr. Emil Fu
Senior VP, International Integration, Fountain Medical Development, China
说明: scientificprogram4_clip_image063.jpg Dr. Jaya Abraham
Vice President, R&D, Alvogen, Taiwan
Dr. Beat Flühmann
Director, Vifor Pharma Ltd, Switzerland
说明: Mingde-Xia.jpg Dr. Ghotas Evindar
Chemistry Group Leader, GlaxoSmithKline, USA
说明: scientificprogram4_clip_image045.jpg Dr. John Lambert
Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China
说明: scientificprogram3_clip_image030.jpg Dr. Gerald J. Yakatan
Chairman & CEO, IriSys, LLC,.USA
Dr. Rashida A.Karmali
CEO & President, Tactical Therapeutics, Inc., USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Chris Triggle
Professor, Weill Cornell Medicine, Qatar
说明: 说明: scientificprogram3_clip_image022.jpg  Dr. Weiyi Zhang
Director, External Innovation China Research Beyond Borders, Corporate Discovery Research, Boehringer-IngelheimPharma, China
说明: 说明: scientificprogram3_clip_image034.jpg Dr. Gert Fricker
Director, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Germany
说明: 说明: scientificprogram3_clip_image016.jpg
Dr. Xinyuan Liu
Academician of Chinese Academy of Sciences, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Jing Li
Senior Vice President, Biologics Discovery, Wuxi Biologics, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Chris Vernall
Business Development Director, Intertek Melbourn, UK
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Robert Borris
Vice-Dean, School of Pharmaceutical Science and Technology, Tianjin University, China
说明: 说明: scientificprogram3_clip_image016.jpg Mr. Thomas Saiying Ko
Chief Technology Officer, BioLingus GmbH, Switzerland
说明: 说明: scientificprogram3_clip_image016.jpg Dr.Jinhua Wang
Principal Investigator, Institute of Medicine, Chinese Academy of Medical Sciences, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Xingchun Gou
Professor, Xi'an Medical University, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Hakim Mohamed
President and CEO, Once Source Clinical & Management, USA
Dr. Rakesh Ranjan
Executive Medical Director, Charak Clinical Research Center, USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Chin-Tarng Lin
Professor, National Taiwan University Hospital, Taiwan
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Ole Winther Rasmussen
Associate Professor, Medical Department, Kolding Hospital, Denmark
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Guo-Ping Zhou
Adjunct Professor, Harvard Medical School, USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Wei Min Huang
Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Shengjun Zhang
Vice President and Chief Medical Officer, JOINN Laboratories, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Iduna Jutta Fichtner
COO, EPO-Experimental Pharmacology and Oncology GmbH, Germany
说明: 说明: scientificprogram3_clip_image016.jpg Dr. James (Jim) Radosevich
Professor, University of Illinois at Chicago, USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Thomas Vorherr
Director Peptide Discovery, Novartis Institutes for BioMedical Research, Switzerland
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Le Sun
President, AbMax Biotechnology Co., Ltd., China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Xiangdong Qu
CEO, QureBio, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. George E. Anastassov
Founder, AXIM Biotechnologies, Inc., USA


Scenery of Nanjing

Nanjing is the capital of Jiangsu Province in East China, running through the city are lower reaches of the Yangtze River whose estuary is not far away. Nanjing enjoys a civilization of over 6000 years and the city itself was founded 2500 years ago. Enclosed by mountains and rivers, and located in a strategic place, it boasts picturesque scenery that blends natural landscape with towering modern buildings, integrating traditional styles with modern civilization. Thus it was known as a unique historic and cultural city to the world.
As one of the Four Ancient Capitals, Nanjing is a vital cradle of Chinese civilization and over a long stretch of time, it has been the political and cultural pivot of South China, thus dubbed as the Capital of Ten Ancient Dynasties, rich in both cultural heritage and historical relics. Among the landmarks of Nanjing there are the City Wall, the Ming Xiaoling Mausoleum, Dr. Sun Yat-sen Mausoleum, Presidential Palace and Confucius Temple.

Past Conference

Program Release
Online Registration
News Release
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organization

Jiangsu Pharmaceutical Association

Operating Organizations

Information Research Center of International Talent, SAFEA

BIT Group Global Ltd.
Supporting Organization

Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China


Official Travel Agency
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.